Shandong Innovative Pharmaceutical Research and Development

Shandong Innovative Pharmaceutical Research and Development (SIPRD) is a China-based biotechnology company focused on the discovery and development of novel small molecule and biologic therapeutics. The company maintains a robust pipeline targeting metabolic diseases, cardiovascular conditions, and gastrointestinal disorders, with several candidates in various stages of clinical trials. SIPRD operates as an integrated R&D entity, often collaborating with larger Chinese pharmaceutical groups to advance its proprietary programs. Their core expertise lies in medicinal chemistry and the optimization of metabolic drug candidates, particularly for the treatment of Type 2 diabetes and hypertension.